Drug companies and clinical trials
Arthur Schafer has a good point in regards to the commercialization of IP, but how can anyone agree with such a paranoid and polorazing view of the drug companies. Banning them completely would only create an underground of business transactions. At least with gifts to the Universities we know who and where the money is dispersed and for what.
It is time the public became more involved in this discussion and that is why we are having a Conference November 4-5, in Toronto to discuss the Scientist as Entrepreneur, with Dr Nancy Olivieri. This is not a controversy that is going to go away and I applaud Professor Schafer for not pretending that it doesn't exist.